Stock OSX OSTEOPORE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Osteopore Limited

Equities

OSX

AU0000053324

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.4 AUD +17.65% Intraday chart for Osteopore Limited +321.05% -39.39%
Apr. 23 Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% MT
Apr. 23 Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 73.9 60.98 26.39 17.59 6.816
Enterprise Value (EV) 2 71.18 52.39 21.94 16.32 6.752
P/E ratio -8.84 x -28.5 x -7.29 x -4.42 x -1.29 x
Yield - - - - -
Capitalization / Revenue 180 x 40.5 x 23.7 x 10.4 x 3.07 x
EV / Revenue 173 x 34.8 x 19.7 x 9.64 x 3.05 x
EV / EBITDA -30.6 x -29.2 x -6.41 x -4.08 x -1.53 x
EV / FCF -31.7 x -40.7 x -8.46 x -6.7 x -6.63 x
FCF Yield -3.15% -2.45% -11.8% -14.9% -15.1%
Price to Book 24.9 x 6.78 x 4.91 x 9.06 x 15.8 x
Nbr of stocks (in thousands) 6,749 7,818 7,818 7,818 10,328
Reference price 3 10.95 7.800 3.375 2.250 0.6600
Announcement Date 3/31/20 3/25/21 3/31/22 3/31/23 4/16/24
1AUD in Million2SGD in Million3AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.9101 0.4116 1.505 1.113 1.692 2.217
EBITDA 1 -0.803 -2.329 -1.797 -3.421 -3.998 -4.401
EBIT 1 -0.8781 -2.367 -1.928 -3.605 -4.175 -4.821
Operating Margin -96.48% -575% -128.16% -323.86% -246.68% -217.41%
Earnings before Tax (EBT) 1 -0.8472 -2.382 -1.946 -3.621 -4.195 -4.828
Net income 1 -0.8472 -2.382 -1.946 -3.621 -4.195 -4.872
Net margin -93.09% -578.8% -129.33% -325.33% -247.89% -219.72%
EPS 2 -58.38 -1.239 -0.2735 -0.4632 -0.5093 -0.5099
Free Cash Flow 1 -0.1566 -2.243 -1.286 -2.593 -2.434 -1.019
FCF margin -17.21% -544.91% -85.45% -232.94% -143.82% -45.96%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/19/19 3/31/20 3/25/21 3/31/22 3/31/23 4/16/24
1SGD in Million2SGD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.56 2.71 8.59 4.44 1.27 0.06
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.16 -2.24 -1.29 -2.59 -2.43 -1.02
ROE (net income / shareholders' equity) 65.6% -227% -32.5% -50.4% -113% -392%
ROA (Net income/ Total Assets) -82.9% -55.5% -16.6% -27.7% -54.5% -86.8%
Assets 1 1.022 4.293 11.73 13.06 7.695 5.615
Book Value Per Share 2 -3.770 0.4400 1.150 0.6900 0.2500 0.0400
Cash Flow per Share 2 2.570 0.4900 1.150 0.5800 0.1600 0.1100
Capex 1 0.06 0.08 0.38 0.19 0.06 0.01
Capex / Sales 7.11% 19.33% 25.33% 17.49% 3.78% 0.33%
Announcement Date 9/19/19 3/31/20 3/25/21 3/31/22 3/31/23 4/16/24
1SGD in Million2SGD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
OSTEOPORE LIMITED Stock Osteopore Limited
-39.39% 2.69M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. OSX Stock
  4. Financials Osteopore Limited